Deutsche Bank’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Deutsche Bank’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,000	Closed	-$27K	–	5661
2015 Q3	$27K	Buy	1,000 +67	+7%	+$2.11K	﹤0.01%	4694
2015 Q2	$22K	Buy	+933	New	+$19.2K	﹤0.01%	4892

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank's LJPC Position: Q4 2021 in Review

Deutsche Bank sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2021, closing a stake of 35 shares.

Deutsche Bank first reported a position in LJPC in Q1 2014 and held it in 30 quarters. The position peaked at $4.04M in Q3 2015. 44 funds tracked by Wall St. Rank hold LJPC as of Q4 2021.

Deutsche Bank reported no remaining La Jolla Pharmaceutical Company position as of Q4 2021 after selling out during the quarter.
Deutsche Bank sold 35 La Jolla Pharmaceutical Company shares in Q4 2021.
Deutsche Bank first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 30 quarters.
Deutsche Bank's La Jolla Pharmaceutical Company position peaked at $4.04M in Q3 2015.
44 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2021.

Based on Deutsche Bank's 13F filing for Q4 2021, filed 11 Feb 2022.